LABCORP HOLDINGS INC. (LH) Options Risk Score
Real-time risk analysis for LH options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full LH options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan LH Now — Free →
Is it risky to sell options on LABCORP HOLDINGS INC. (LH) right now?
Over a 4-week expiry window, LABCORP HOLDINGS INC. (LH) scores 92 out of 100 for options catalyst risk (HIGH). What pushes it there: an upcoming earnings report, 5 recent news items, 10 active legal filings and 22 clinical-trial catalysts, all landing inside the 4-week window. A HIGH reading (70+) means LH has a dated event inside the window, so an option sold here carries gap risk that time decay alone will not pay for. The score ranks event exposure, not the likely direction of the move.
LH shows an IV Rank of 72 — implied volatility is near the top of its own one-year range, so LH options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 32%. IV Rank answers how LH options are priced against their own history, which is the starting point for choosing between selling and buying premium.
The 2026-07-30 earnings report sits inside a standard monthly expiry for LH, so implied volatility should stay bid into the date and drop sharply once it passes.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer